div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentrsu-2021-5-26-adenovirus-type-5-vectored-covid-19-vaccine-in-healthy-adultshtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: RSU · 2021 5 26 · adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised double-blind placebo-controlled phase 2 trial The Lancet loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader036fdocumentsinreader036viewer20220716086146f079f4263007b1357f29html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentrsu-2021-5-26-adenovirus-type-5-vectored-covid-19-vaccine-in-healthy-adultshtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: RSU · 2021 5 26 · adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised double-blind placebo-controlled phase 2 trial The Lancet loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader036fdocumentsinreader036viewer20220716086146f079f4263007b1357f29html5thumbnails2jpg width=140 height=200 divdiv